Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7758582 | 1.00 | MMP2 (0.57) | MMP2MMP3 | |
| SCHEMBL7758485 | 0.94 | MMP2 (0.52) | MMP2MMP3 | |
| SCHEMBL7758477 | 0.94 | MMP2 (0.52) | MMP2MMP3 | |
| SCHEMBL7758573 | 0.79 | MMP2 (0.71) | MMP2MMP3 | |
| SCHEMBL7765046 | 0.78 | MMP2 (0.53) | MMP2MMP3 | |
| SCHEMBL7758482 | 0.76 | MMP2 (0.62) | MMP2MMP3 | |
| SCHEMBL7761567 | 0.75 | MMP2 (0.60) | MMP2MMP3 | |
| SCHEMBL7761563 | 0.75 | MMP2 (0.60) | MMP2MMP3 | |
| SCHEMBL7763695 | 0.73 | MMP2 (0.73) | MMP2MMP3 | |
| SCHEMBL7758741 | 0.73 | MMP2 (0.69) | MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1098662-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2001-05-16 | — | — | EP | claimed |
| WO-2000004892-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2000-02-03 | — | — | WO | claimed |
| EP-1098662-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2001-05-16 | — | — | EP | disclosed |
| WO-2000004892-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2000-02-03 | — | — | WO | disclosed |